Hematology/Oncology

• In the Journals

• Risk factors identified for locoregional recurrence in triple-negative breast cancer

• May 16, 2013
• Increasing age and the presence of lymphovascular invasion were among several predictors of locoregional recurrence in a cohort of women with...More »

• In the Journals

• Pregnancy did not affect maternal prognosis of breast cancer

• May 10, 2013
• Women who were diagnosed with breast cancer during pregnancy experienced similar DFS and OS rates as women who were not pregnant, according to study...More »

• FDA public health advisories

• FDA: Confusion between names of breast cancer drugs may cause medication errors

• May 6, 2013
• Incorrect use of the non-proprietary name for a newly approved breast cancer therapy in electronic medical record systems may cause confusion that results...More »

• In the Journals

• Breast cancer survivors not meeting minimum exercise recommendations

• May 6, 2013
• Nearly four of every five breast cancer survivors do not meet national exercise recommendations 10 years after their diagnosis, study results showed.
  At...More »

• Meeting News Coverage

• IMRT showed fewer adverse effects than standard radiotherapy

• May 3, 2013
• Intensity-modulated radiotherapy reduced adverse effects of radiation in patients with early breast cancer, according to results presented at the 2nd...More »

• Cover Stories

• Nanoparticles offer ‘infinite’ possibilities for cancer treatment

• HemOnc Today, May 10, 2013
• After more than 3 decades of intense research, nanotechnology has moved out of the fiction realm and into the scientific.
  Preliminary data suggest...More »

• In the Journals

• Gemcitabine/paclitaxel improved PFS, OS in metastatic breast cancer

• April 30, 2013
• Maintenance therapy with paclitaxel and gemcitabine improved PFS and OS in women with metastatic breast cancer who initially exhibited disease control...More »

• Meeting News Coverage

• Exercise lowered estrogens, breast cancer risk in postmenopausal women

• April 24, 2013
• Results of a study presented at the American Association for Cancer Research Annual Meeting have given researchers a better idea of the potential...More »

• In the Journals

• Addition of lapatinib to paclitaxel extended survival in HER-2 breast cancer

• April 23, 2013
• The addition of lapatinib to paclitaxel conferred significant improvements in OS among patients with newly diagnosed, HER-2–positive metastatic...More »

• In the Journals Perspective

• USPSTF issues breast cancer risk reduction recommendation

• April 15, 2013
• The US Preventive Services Task Force today recommended shared decision-making between clinicians and women at risk for breast cancer regarding the use of...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!